|
Market Closed -
Nasdaq
16:00:00 2026-10-26 EDT
|
5-day change | 1st Jan Change | ||
| 38.02 USD | -0.11% |
|
+7.89% | +16.16% |
| 10-12 | BofA Securities Initiates Axogen at Buy, $52 Price Target | MT |
| 10-07 | Barclays Initiates Coverage on Axogen With Overweight Rating, $55 Price Target | MT |
Company Valuation: Axogen, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 389.4 | 422 | 294 | 725.3 | 1,510 | 2,231 | - | - |
| Change | - | 8.37% | -30.34% | 146.7% | 108.14% | 47.77% | - | - |
| Enterprise Value (EV) | 389.4 | 422 | 294 | 725.3 | 1,510 | 2,231 | 2,231 | 2,231 |
| Change | - | 8.37% | -30.34% | 146.7% | 108.14% | 47.77% | 0% | 0% |
| P/E | -14.4x | -14.5x | -13.4x | -71.7x | -96.3x | -96.3x | 346x | 93.2x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | -2.36x | 0.5x | 1.3x | -2x | -6x | -3x | 0x |
| Capitalization / Revenue | 3.06x | 3.05x | 1.85x | 3.87x | 6.7x | 7.81x | 6.07x | 5.06x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 7.81x | 6.07x | 5.06x |
| EV / EBITDA | -0x | -0x | -0x | 0x | 0x | 64.7x | 41.8x | 27.5x |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -2,600x | 229x | 157x |
| EV / FCF | - | -0x | -0x | - | -0x | 299x | 69.9x | 45.5x |
| FCF Yield | - | -8.56% | -6.66% | - | -0.19% | 0.33% | 1.43% | 2.2% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.65 | -0.69 | -0.51 | -0.23 | -0.34 | -0.395 | 0.11 | 0.408 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 127.4 | 138.6 | 159 | 187.3 | 225.2 | 285.6 | 367.4 | 440.9 |
| EBITDA 1 | -19.94 | -9.259 | -1.12 | 19.84 | 27.92 | 34.47 | 53.39 | 81.02 |
| EBIT 1 | -25.42 | -29.71 | -21.46 | -3.287 | -7.849 | -0.8579 | 9.761 | 14.24 |
| Net income 1 | -26.98 | -28.95 | -21.72 | -9.964 | -15.7 | -22.51 | 5.563 | 19.94 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 9.37 | 9.98 | 6.83 | 16.48 | 32.73 | 38.02 | 38.02 | 38.02 |
| Nbr of stocks (in thousands) | 41,563 | 42,287 | 43,044 | 44,008 | 46,122 | 58,672 | - | - |
| Announcement Date | 2/22/22 | 3/14/23 | 3/5/24 | 2/25/25 | 2/24/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -96.25x | - | - | - | 2.23B | |
| 35.1x | 5.94x | 22.79x | 0.27% | 253B | |
| 37.04x | 7.02x | 21.99x | 0.62% | 164B | |
| 52.06x | 12.62x | 27.08x | -.--% | 157B | |
| 17.3x | 3.43x | 11.16x | -.--% | 66.06B | |
| 48.71x | 12.05x | 26.55x | -.--% | 51.52B | |
| 20.71x | 2.48x | 12.52x | 2.44% | 52.64B | |
| 35.9x | 7.18x | 22.72x | -.--% | 52.2B | |
| 34.29x | 6.79x | 23.06x | 0.58% | 49.61B | |
| 79.82x | 7.59x | 23.06x | -.--% | 44.8B | |
| Average | 26.47x | 7.23x | 21.22x | 0.44% | 89.27B | |
| Weighted average by Cap. | 38.97x | 7.48x | 22.17x | 0.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- AXGN Stock
- Valuation Axogen, Inc.
Select your edition
All financial news and data tailored to specific country editions
